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Abstract
Background: In patients with Type 1 Diabetes (T1D) who develop microalbuminuria, progressive decline in glomerular
filtration rate (GFR) may be initiated by leakage into the urine of toxic proteins (txUPs). This study tested this hypothesis.
Methods: After archiving baseline urine, we followed T1D patients with microalbuminuria for 8–12 years to distinguish
those in whom GFR declined (Decliners) and those in whom it remained stable (Non-decliners). Human proximal tubular
cells (HK-2 cells) were grown in serum-free medium enriched with pooled urines from Decliners or Non-decliners. We
determined genome-wide expression profiles in extracted mRNA.
Results: The two pooled urines induced differential expression of 312 genes. In terms of gene ontology, molecular functions
of the 119 up-regulated genes were enriched for protein binding and peptidase inhibitor activities. Their biologic processes
were enriched for defense response, responses to other organisms, regulation of cellular processes, or response to stress or
stimulus, and programmed cell death. The 195 down-regulated genes were disproportionately represented in molecular
functions of cation binding, hydrolase activity, and DNA binding. They were disproportionately represented in biological
processes for regulation of metabolic processes, nucleic acid metabolic processes, cellular response to stress and
macromolecule biosynthesis. The set of up-regulated genes in HK-2 cells overlaps significantly with sets of over-expressed
genes in tubular and interstitial compartments of kidney biopsies from patients with advanced DN (33 genes in one study
and 25 in the other compared with 10.3 expected by chance, p,10
29 and p,10
24, respectively). The overlap included
genes encoding chemokines and cytokines. Overlap of down-regulated genes was no more than expected by chance.
Conclusions: Molecular processes in tubules and interstitium seen in advanced diabetic nephropathy can be induced in
vitro by exposure to urine from patients with minimal microalbuminuria who subsequently developed progressive renal
function decline, presumably due to putative txUPs.
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Introduction
Moderate elevation of urinary albumin excretion, referred to as
microalbuminuria (MA), is the earliest indicator of diabetic
nephropathy (DN) in Type 1 diabetes (T1D) [1]. However, while
MA is a very sensitive marker, it is not specific for the disease
process that leads to renal failure. In two Joslin studies of the
natural history of MA, only a third of the patients experienced
renal function loss as reflected in a progressive decline in the
glomerular filtration rate (GFR) during the subsequent 4–12 years
of follow-up [2–4]. Renal function was stable and normal in the
rest. We designate this decline as early progressive GFR loss
because it began soon after onset of MA when GFR was normal or
even elevated. Nevertheless, it persisted during follow-up and
eventually led to impaired renal function and end-stage renal
disease (ESRD) [2,3].
Investigation of systemic factors has identified several that
contribute to the risk of early GFR loss, such as older age, elevated
HbA1c, elevated blood pressure, high normal values of serum uric
acid and elevated levels of circulating TNF-Rs [2–4]. In addition
to systemic factors, we have been searching for urinary markers
associated with early GFR loss. For example, as reported by
Wolkow et al., urinary concentrations of IL-6, IL-8, MCP-1, IP-10
and MIF are elevated in those patients with MA who later
developed early GFR loss (Decliners) in comparison with those
whose renal function remained stable and normal (Non-decliners).
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these chemokines were similar in their serum [5].
Plausible, explanations for the different concentrations of these
chemokines in the urine but not in the blood include differences in
the rate of clearance of these chemokinases between Decliners and
Non-decliners, as well as differences in sensitivity and detectability
of the assays used. While the first possibility needs further study,
the second possibility is unlikely considering the performance of
the assays used in our study.
An alternative explanation for the findings reported by Wolkow
et al. [5] is that kidney cells, primarily tubular, are the source of
the elevated urinary concentrations of these chemokines. Al-
though, the nature of the stimulus to synthesize these chemokines
in tubular cells is unknown, it might originate from the glomerular
filtrate. We hypothesize that impairment of the glomerular
filtration barrier (evidenced by the presence of MA) permits
injurious serum proteins or growth factors to leak into the urinary
space. These putative factors, which we refer to as toxic urinary
proteins (txUPs), may stimulate proximal tubular cells to secret
chemokines/cytokines and other stress proteins indicating tubular
damage that leads to tubular atrophy, interstitial fibrosis and early
GFR loss. Recently it has been demonstrated in animal studies
that tubular damage initiates a disease process that leads to
inflammation, loss of blood vessels, interstitial fibrosis and
glomerulosclerosis [6].
Here we report an in vitro study of the effects of urine on gene
expression profiles in human proximal tubular cells (HK-2 cells).
We postulate that exposure of HK-2 cells to urine from Decliners
would induce a different gene expression profile than that induced
by exposure to urine from Non-decliners due to the presence of
putative txUPs in the former and their absence (or lower
concentration) in the latter. The differentially expressed genes
may reveal disease processes taking place in tubules during the
development of early GFR decline in T1D.
Earlier expression studies include the analysis of candidate genes
or candidate pathways (biased approach) in kidney tissue from
diabetic rodent models and diabetic humans [7,8]. Similarly,
studies of a limited number of candidate genes and proteins have
been conducted in vitro in HK-2 cells. Cells were exposed to urine
from patients with severe proteinuria or urine from patients with
focal glomerulosclerosis and patients with idiopathic minimal
change disease, and the results were compared [9,10]. In contrast,
we used an unbiased genome-wide approach to characterize gene
expression in our study of urines from patients with MA. All
patients had normal renal function when their urine was collected,
but during 10–12 years of follow-up, renal function became
impaired in half and remained normal in the others. In this study
we sought to identify differences in gene expression in HK-2 cells
that might reflect exposure to putative txUPs present in the urine
of patients who subsequently developed impaired renal function.
Recently, unbiased genome-wide transcriptome approaches
have been applied to kidney tissue from patients with DN. Two
studies catalogued gene expression profiles in microdissected
human renal glomerula and tubules and interstitium obtained
from kidneys with advanced DN and individuals who were healthy
or diagnosed with minimal change disease. Gene expression was
correlated with eGFR in the examined patients [11,12]. These
findings are compared with the results of our transcriptome
analysis in HK-2 cells.
Subjects and Methods
The Committee of Human Studies of the Joslin Diabetes Center
approved the study, its protocols and informed consent proce-
dures. Informed consent was obtained in writing from all
participants involved in the study.
Study design and study groups
This study examined in vitro effects of the putative txUPs on gene
expression profiles in HK-2 cells using urine specimens obtained
from two sets of patients; those who developed early eGFR decline
during follow-up (Decliners) and those with stable eGFR during
follow-up (Non-decliners).
All patients were Caucasian participants in the follow-up study
titled ‘‘The Joslin Study on Natural History of Early Nephropathy
in Type 1 Diabetes’’. The urines for this project were obtained
from patients who developed new onset MA and were subse-
quently followed for 8–12 years. Findings regarding changes in
urinary albumin excretion and trajectories of renal function
decline in these patients were reported by Perkins et al. and
Merchant et al. [2,13]. Urine specimens obtained from 79 of these
patients were previously used in the proteomic study by Merchant
et al. [13]
For the current study we identified 17 patients for whom we had
urine specimens that met the following criteria. The specimen was
obtained 2–5 years after onset of MA, and at least 10 ml of
archived urine remained. Serial measurements of cystatin C in
sera obtained during follow-up were used to trace the trajectory of
estimated GFR. The patients were classified as Decliners and
Non-decliners according to criteria described previously [3].
Briefly, patients with a GFR loss 3.3%/year or faster were
considered Decliners. Patients with slower loss were considered
Non-decliners.
Tests for contamination with endotoxins (Pyrogent Plus single
test kit, Cambrex, Walkersville, MD) eliminated two specimens.
From the remainder, we selected five from Decliners and five from
Non-decliners whose characteristics were most similar (see
Table 1). These urines were concentrated using columns with
cutoff 5 kD (Millipore Amicon Ultra – 4, Billerica, MA).
Pooling urine specimens
To reduce the study cost, we pooled the concentrated urines
from Decliners and Non-decliners into two samples, thereby
reducing the number of RNA specimens to be processed from 60
to 12. The urine pools were added to serum-free K-SFM medium
(Keratinocyte serum free medium - Invitrogen, GIBCO, Cat
No. 17005-042) to give a final urinary albumin concentration that
was 2.0 times that in the original samples. Glucose concentration
Table 1. Clinical characteristics of patients at the time study-
urine samples were obtained according to whether renal
function subsequently declined or was stable during 8–10
year follow-up (data are medians and range).
Decliners Non-decliners
Men/Women (n/n) 4/1 4/1
Age at DM Dx (yrs) 12 14
Duration of DM (yrs) 21 24
HbA1c (%) 8.7 8.1
Urinary albumin (mg/ml) 61 49
cC-GFR (ml/min) 83 91
Rate of cC-GFR decline (%/yr) 3.5–12.1 0.5–2.0
cC-GFR estimated glomerular filtration rate based on serum cystatin C.
doi:10.1371/journal.pone.0057751.t001
Urines from Early GFR Loss Toxic to HK-2 Cells
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e57751was 25 mMol in the culture medium, which was changed every
other day.
In vitro Experiments
Cultured HK-2 cells (immortalized human PTC, 80% conflu-
ent) (ATCC, Manassas, VA) were exposed to K-SFM serum free
medium combined with pooled urine from either Decliners or
Non-decliners. Each experiment consisted of four cell cultures.
Two were exposed to pooled urines from Decliners, one for
6 hours and one for 24 hours. Similarly, two were exposed to
pooled urines from Non-decliners, one for 6 and one for 24 hours.
The experiments were repeated three times several weeks apart.
After completion of all experiments, RNA was isolated from the
HK-2 cells with RNeasy Micro Kit (Qiagen, Germantown, MD).
The twelve specimens were analyzed for RNA quantity and
normalized. cDNA was synthesized and hybridized with the
Illumina SentrixH Beadchip Array Human-6 (San Diego, CA) to
obtain gene expression profiles. The chip had 24,000 probes that
covered 19,600 genes. Array hybridization, washing, and scanning
were performed by the core facility at the Enders Institute,
Children’s Hospital, Boston, MA according to Illumina-recom-
mended protocols (San Diego, CA).
Data Analysis
Raw expression data were analyzed with dChip software (www.
dchip.org). Raw intensity values were normalized with an
invariant set normalization method [14]. The criteria for
identifying expression differences in the normalized data were: a
fold change between Decliners and Non-decliners $1.3 (up-
regulated) or #0.77 (down-regulated); an expression difference
threshold for the absolute difference .100; and a P-value ,0.05.
The overlap between up-regulated genes in HK2 cells and up-
regulated genes in biopsies was tested by a Fisher’s exact test, and
the overlap of down-regulated genes was tested similarly.
Gene ontology analyses
Significantly regulated genes were analyzed for enrichment of
gene ontology (GO) terms (molecular function and biological
processes) using Genomatix pathway system software (http://
www.genomatix.de). The report for each annotation included the
observed and expected numbers of genes, the p value, and the
total number of genes in the annotation. Because proteins
frequently have different molecular functions and involvement in
multiple biological processes, the same gene may be included in
several different GO terms. To reduce redundancy (one gene
present in many downstream terms) and gain an overview of
general biology, significant GO terms for molecular function (MF)
(p,0.01) were retrieved upstream towards its ancestors based on
the GO Inferred Tree View (http://www.geneontology.org/,
AMIGO version 1.8) in a manner similar to that described in
DAVID: Database for Annotation, Visualization, and Integrated
Discovery [15]. The different levels provided by Inferred Tree
View allow users to annotate lists of genes at different levels of
generality and specificity. Level 1 represents the most general
categories and provides the most coverage, whereas Level 5
provides more specific information and less coverage. The GO
vocabulary is a hierarchy, so a term at level 5 is a child of a term at
level 1 for a given gene (note that for some genes there will be
more than 5 levels). For a good balance between specificity and
coverage, the terms presented in this analysis are at the fourth level
downstream from the start of a molecular function (GO:0003674
molecular function (472694 gene products)). For biological
processes (BP), a large number of terms passed the significance
cut off (p,0.01), so only the 20 BP terms with the smallest P-values
below 10
26 were selected for analysis. As was done for molecular
function terms, BP terms are presented at the fourth level
downstream from the start of a biological process (GO:0008150
biological process (443783 gene products)). In this report we
considered only GO terms that had 5 or more genes observed.
The original files of significant GO terms with the most specific
categories using terminal nodes are available upon request.
Concordance between genes differentially expressed in
HK-2 cells and genes differentially expressed in kidney
biopsies of patients with DN
We compared our results in HK-2 cells with gene expression
profiles in tubular and interstitial compartments of kidney biopsies
obtained from patients with diabetes and various degrees of renal
function impairment that were reported by Schmid et al. [11] and
by Woroniecka et al. [12] deposited in Nephromine. The biopsies
in Woroniecka’s study were taken from 12 non-diabetic controls
and 12 cases with advanced DN. The expression data were
combined, and Spearman correlation coefficients were determined
between gene expression and eGFR. The biopsies in Schmid’s
study were taken from 12 patients with advanced DN (proteinuria
and a broad range of renal function impairment). Spearman
correlation coefficients were determined between expression data
and renal function. Both studies used Affymetrix arrays
(n=12,600 genes). Although the Illumina array used in the
present study contained 19,600 genes, we used only the genes
present on the Affimetrix array for comparison with Nephromine
data.
Figure 1. Plot of the gene expression level in HK2 cells exposed
to urine from Decliners against the gene expression level in
HK2 cells exposed to urine from Non-decliners. Broken diagonal
lines represent fold changes of 1.3 and 0.77. Panel A: Expression levels
after 6-hour exposure. Panel B: Expression levels after 24-hour
exposure.
doi:10.1371/journal.pone.0057751.g001
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Study design and characteristics of the study group
Clinical characteristics of Decliners and Non-decliners are
summarized in Table 1. At baseline, when urine specimens were
obtained, the distributions of age at diagnosis of diabetes, duration
of diabetes, and HbA1c were similar in both groups. Furthermore,
estimated GFR (based on serum cystatin C) was normal in
Decliners and Non-decliners and urinary albumin excretion was
only moderately elevated. However, by design, Decliners and
Non-decliners differed with regard to GFR change during follow-
up. Decliners had significant GFR loss per year, whereas Non-
decliners had minimal GFR changes. After 8–12 years of follow-
up, average eGFR was 44 ml/min in Decliners and 82 ml/min in
Non-decliners.
The urines were concentrated two fold and combined into a
pooled urine from Decliners and a pooled urine from Non-
decliners. The pools were added to serum-free tissue culture media
in which HK-2 cells were grown. Two exposure times, 6 and
24 hours, were selected to increase the chance of detecting genes
with different time-courses of expression during exposure. After
completion of all experiments, HK-2 cells were collected and
mRNA isolated. Genome-wide expression profiles were deter-
mined with the Illumina SentrixH Beadchip Array Human-6.
Gene expression profiles in HK-2 cells according to
exposure time
After normalization of the expression data, we applied pre-
defined criteria to identify expression differences: a fold-change
($1.3 or #0.77) and a nominal p-value (P,0.05). After 6-hour
exposure 274 genes and after 24-hour exposure 154 genes were
differentially expressed. Normalized expression of these genes is
illustrated in Figure 1 with expression after exposed to Decliner
urine plotted against that after exposure to Non-decliner urine. Of
the genes differentially expressed after 6-hour of exposure, 99 were
up-regulated and 175 down-regulated (Panel A). Similarly, of the
genes differentially expressed after 24-hour exposure, 39 genes
were up-regulated and 115 down-regulated (Panel B).
In total, 314 genes were differentially expressed at one or both
exposure times. The distribution of these genes according to the
temporal pattern of expression is shown in Table 2. Of the 119 up-
regulated genes; 36 were up-regulated persistently (after both
exposures), 67 were up-regulated temporarily (at 6-hours only),
and 16 were up-regulated after a delay (at 24-hours only). Of the
195 down-regulate genes, 138 were down-regulated persistently,
45 genes were down-regulated temporarily, and 12 genes were
down-regulated after a delay. All 314 are listed alphabetically in
Table S1 according to temporal pattern of expression.
GO analysis of genes differentially expressed in HK-2 cells
To identify GO terms (e.g. molecular function and biological
processes) that are enriched in HK-2 cells in response to exposure
to Decliner urine, we analyzed differentially expressed genes with
Genomatix pathway system software (http://www.genomatix.de).
Among the differentially expressed genes we found GO terms
significantly enriched at level 5 for molecular function and
biological processes. As described in Methods, to reduce
redundancy (one gene present in many downstream terms) and
gain an overview of general biology, the GO terms were retrieved
upstream towards their ancestors up to level 4. For this analysis we
considered GO terms that were significant at p,0.01 at level 5.
Since there were hundreds of terms for biological processes
significantly enriched at this level, we restricted analysis to the 20
terms with the lowest P-values (p,10
26).
Results of GO analysis for the 119 up-regulated genes are
summarized in Tables 3 & 4. The two molecular function terms
Table 2. Distribution of differentially expressed genes in HK2 according to their pattern of expression after 6-hour and 24-hour
exposures cells to urine from Decliners or Non-decliners.
Pattern of expression:
6-hr exposure 24-hr exposure Number of genes
Numbers of genes correlated with eGFR in
Nephromine
Up Up 36 17 (47%)
Up Normal 67 15 (22%)
Normal Up 16 9 (56%)
Down Down 138 13 (9%)
Down Normal 45 6 (13%)
Normal Down 12 3 (25%)
Total 314 63 (20%)
doi:10.1371/journal.pone.0057751.t002
Table 3. Enriched GO molecular function terms for 119-up-regulated genes in HK-2 cells (Significantly enriched (P,0.01) GO terms
were retrieved upstream towards its ancestors to level 4).
GO-term IDs GO-term # Genes observed # Genes expected # Genes total List of observed genes
5102 Receptor binding 22 6.95 1003 ADM, ADRB2, BID, C3, CCL2, CCL5, CCL20, CSF2,
CXCL2, CXCL3, EBI3, HBEGF, ICAM1, IL6, IL8, JAK1,
LYN, NAMPT, NEDD4, SAA1, SERPINE1, TNFSF10
30414 Peptidase inhibitor activity 6 1.13 163 C3, SERPINE1, SERPINB8, SLPI, TNFAIP3, WFDC2
doi:10.1371/journal.pone.0057751.t003
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following. The first included genes that encode for receptor
binding. Among all human genes, 1003 are classified under this
term, and 22 of them were over-expressed in our study while only
6.95 were expected if differential expression had been by chance.
It is interesting that among the 22 included genes, many encode
chemokines and cytokines. The second enriched term included
peptidase inhibitor activity. Out of a total of 163 human genes in
this term, six were up-regulated while 1.13 were expected. With
regard to GO terms for biological process the up-regulated genes
were enriched in the following processes: defense response,
response to other mechanisms, regulation of response to stress,
regulation of response to stimulus and programmed cell death.
Results of GO analysis for the down-regulated genes are
summarized in Tables 5 & 6. These genes were disproportionately
represented in GO terms for molecular functions such as cation
binding, hydrolase activity acting on ester bonds, and DNA
binding. With regard to GO terms for biological process, the
down-regulated genes were disproportionately represented in the
following processes: regulation of metabolic processes, nucleic acid
metabolic processes, cellular macromolecule metabolic processes,
cellular response to stress and macromolecule biosynthetic
processes.
Table 4. Enriched GO biological process terms for 119 up-regulated genes in HK2 cells (top 20 significantly enriched BP terms
(p,0.01) were retrieved upstream towards its ancestors to level 4).
GO Term Ids GO Term # Genes observed # Genes expected # Genes total List of observed genes
6952 Defense response 29 6.72 910 ADRB2, C3, CCL2, CCL20, CCL5, CD40, CXCL2, CXCL3, ELF3,
ICAM1, IFNGR1, IL6, IL8, IRAK3, JAK1, LCN2, LYN, NFKB1,
NFKBIA, PTX3, SAA1, SAA4, SERPINE1, STAT1, STAT5A, TFRC,
TNFAIP3, TNFRSF1B, TNIP1
51707 Response to other
organism
17 3.23 437 ADM, CCL2, CCL5, CCL20, CXCL2, ICAM1, IFNGR1, IL6, IL8,
IRAK3, LCN2, NFKBIA, PIM2, PTX3, SERPINE1, STAT1, TNFAIP3
50794 Regulation of cellular
process
65 48.73 6593 ADM, ADRB2, ARF4, BCL2A1, BID, BIK, BIRC3, C3, CCL2, CCL20,
CCL5, CCNE2, CD40, CNIH, CSF2, DDR1, DNAJB6, EBI3, EIF4B,
ELF3, FNDC3B, FOSL2, HBEGF, HSP90AA1, ICAM1, IFNGR1, IL6,
IL8, IRAK3, JAK1, LCN2, LGR4, LYN, MAPK6, MIER1, MMP7,
NAB1, NAMPT, NAP1L1, NBN, NEDD4, NFKB1, NFKBIA, PIM2
PLAT, PTX3, RAC2, RCAN1, SAA1, SAT1, SDC4, SERPINE1,
SH3BP1, SLC11A2, SOD2, SRPK1, ST5, STAT1, STAT5A, TNFAIP3,
TNFRSF1B, TNFRSF9, TNFSF10, TRAF1, TRIM16
80134 Regulation of response
to stress
18 3.62 490 ADRB2, C3, CCL5, HBEGF, IFNGR1, IL6, IRAK3, JAK1, LYN,
NFKB1, NFKBIA, PLAT, SAA1, SERPINE1, STAT1, STAT5A,
TNFAIP3, TNFRSF1B
48583 Regulation of response
to stimulus
30 13.07 1769 ADRB2, C3, CCL5, CD40, CSF2, HBEGF, ICAM1, IFNGR1, IL6, IL8,
IRAK3, JAK1, LYN, MIER1, NEDD4, NFKB1, NFKBIA, PIM2, PLAT,
RAC2, SAA1, SERPINE1, ST5, STAT1, STAT5A, TNFAIP3,
TNFRSF1B, TNFSF10, TRAF1, TRIM16
12501 Programmed cell death 29 9.78 1323 ADM, ADRB2, BCL2A1, BID, BIK, BIRC3, CCL2, CCL5, CD40, CSF2,
DNAJB6, IL6, LCN2, NFKB1, NFKBIA, PIM2, RNF144B, SERPINE1,
SLC11A2, SOD2, STAT1, STAT5A, TJP2, TNFAIP3, TNFRSF1B,
TNFRSF9, TNFSF10, TRAF1, ZC3H12A
doi:10.1371/journal.pone.0057751.t004
Table 5. Enriched GO molecular function terms for 195 down-regulated genes in HK-2 cells (Significantly enriched (P,0.01) GO
terms were retrieved upstream towards its ancestors to level 4).
GO-term Ids GO-term # Genes observed # Genes expected # Genes total List of observed genes
43169 Cation binding 36 30.26 3888 AIRE, APOBEC3A, CXXC5, DBF4, ERAP2, MICAL3, MSRB3,
OVOL2, PDLIM5, PTGS2, PXN, SMAP1, SUV39H2, TRIM58,
TRIM74, TTF2, XIAP, XPNPEP3, ZMAT3, ZNF14, ZNF33A,
ZNF417, ZNF430, ZNF454, ZNF542, ZNF549, ZNF608,
ZNF620, ZNF623, ZNF652, ZNF665, ZNF667, ZNF786,
ZNF791, ZNF91, ZNF98
16788 Hydrolase activity,
acting on ester bonds
15 6.84 717 ARSG, ARSK, CDC14B, CDC25B, CTDSPL, DUSP1, DUSP19,
DUSP5, EXOSC2, N4BP2, NT5C2, OLAH, PNPLA8, PPME1,
USP14
3677 DNA binding 35 21.84 2287 AHR, AIRE, BLZF1, CREB1, CXXC5, DMC1, FOXL2, GABPB2,
GTF3C6, LRRFIP1, MCM8, MITF, MSH3, NAT14, NFAT5,
NFATC3, OVOL2, RAD51L1, TTF2, ZNF14, ZNF33A, ZNF417,
ZNF430, ZNF454, ZNF542, ZNF549, ZNF620, ZNF623,
ZNF652, ZNF665, ZNF667, ZNF786, ZNF791, ZNF91, ZNF98
doi:10.1371/journal.pone.0057751.t005
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cells and in tubulointerstitial fraction obtained from
biopsies of human kidney with advanced DN
An additional goal of our study was to determine the extent of
overlap between [1] disease processes (as reflected in gene
expression) that were initiated in our in vitro study of putative
txUPs in urines of patients who subsequently developed renal
function decline and [2] the disease processes observed in tubules
and interstitium in biopsies from kidneys of patients with DN.
Toward that end, we used the findings reported by Woroniecka’s
et al. and Schmid et al., both of whom studied the same Affymetrix
subset of 12,600 genes [11,12]. For this comparison, we restricted
our Illumina dataset of 19,600 genes to that same subset. This
reduced the available number of down-regulated or up-regulated
genes in our dataset from 195 to 114 and 119 to 103, respectively.
The overlaps among the three datasets are illustrated with a Venn
diagram (Figure 2). For the biopsy studies, the investigators related
a gene’s expression in tubular and interstitial compartments of
kidney biopsies obtained from patients with advanced DN to that
patient’s eGFR using the Spearman correlation coefficient. A
positive correlation (low expression together with low eGFR and
high expression with high eGFR) was interpreted as linking eGFR
loss with down-regulation of gene expression. A negative
correlation (high expression together with low eGFR and low
expression with high eGFR) was interpreted as linking eGFR loss
with up-regulation.
The 10% of genes with the strongest positive correlations with
eGFR were deemed down-regulated: 1260 in the data of
Woroniecka et al. [12] and 1262 in the data of Schmid et al.
[11]. Overlap of these two subsets with each other and with the
114 genes down-regulated in HK-2 cells by exposure to urine from
Decliners is shown in Figure 2A. Of the down-regulated genes in
HK-2 cells, only eight were common to the Woroniecka et al.
subset, and fourteen to the Schmid et al. subset. Overlaps of 11.4
genes were expected due to chance; thus, neither was statistically
significant. Down-regulated genes in HK-2 cells were not
considered further.
The 10% of genes with the strongest negative correlations with
eGFR were deemed up-regulated: 1260 in the data of Woroniecka
et al. [12] and 1262 in the data of Schmid et al. [11]. Overlap of
these two subsets with each other and with the 103 genes up-
regulated in HK-2 cells by exposure to urine from Decliners is
Table 6. Enriched GO biological process terms for 194 down-regulated genes in HK2 cells (top 20 significantly enriched BP terms
(P,0.01) were retrieved upstream towards its ancestors to level 4).
GO Term IDs GO Term # Genes observed # Genes expected # Genes total List of observed genes
19222 Regulation of
metabolic process
47 33.46 3691 AHR, AIRE, ATG10, BLZF1, CDC14B, CDC25B, CREB1,
DLC1, DUSP1, DUSP19, DUSP5, FOXL2, GABPB2, HIPK2,
ID1, ID2, ITCH, ITGB3, KCNH6, LRRFIP1, MAP3K9, MITF,
MSH3, NFAT5, NFATC3, NPR1, OVOL2, PCSK9, PTGS2,
PXN, SMAP1, SYDE2, TADA3, USP14, ZNF14, ZNF33A,
ZNF417, ZNF430, ZNF454, ZNF542, ZNF549, ZNF620,
ZNF667, ZNF786, ZNF791, ZNF91, ZNF98
6139 Nucleobase-containing
compound metabolic
process
47 38.00 4192 AHR, AIRE, BLZF1, C9orf80, CDC14B, CREB1, DBF4,
DMC1, EXOSC2, FOXL2, GABPB2, GTF3C6, HIPK2, ID1,
ID2, INTS3, ITCH, KCNH6, LRRFIP1, MCM8, MITF, MSH3,
NAT14, NFAT5, NFATC3, OVOL2, RAD51L1, RPL21, RPSA,
SMG1, SRRM2, TADA3, TEP1, TTF2, ZNF14, ZNF33A,
ZNF417, ZNF430, ZNF454, ZNF542, ZNF549, ZNF620,
ZNF667, ZNF786, ZNF791, ZNF91, ZNF98
90304 Nucleic acid metabolic
process
35 31.27 3449 AHR, AIRE, BLZF1, CREB1, FOXL2, GABPB2, GTF3C6,
HIPK2, ID1, ID2, ITCH, KCNH6, LRRFIP1, MITF, NAT14,
NFAT5, NFATC3, OVOL2, RPL21, RPSA, TADA3, TTF2,
ZNF14, ZNF33A, ZNF417, ZNF430, ZNF454, ZNF542,
ZNF549, ZNF620, ZNF667, ZNF786, ZNF791, ZNF91,
ZNF98
44260 Cellular macromolecule
metabolic process
67 50.93 5618 AHR, AIRE, ATG10, BLZF1, C9orf80, CDC14B, CDC25B,
CREB1, DBF4, DLC1, DMC1, DUSP1, DUSP19, DUSP5,
EXOSC2, FOXL2, FUT6, GABPB2, GNPNAT1, GTF3C6,
HIPK2, ID1, ID2, INTS3, ITCH, ITGB3, KCNH6, LRRFIP1,
MAP3K9, MCM8, MITF, MRP63, MSH3, MSRB3, NAT14,
NFAT5, NFATC3, NPR1, OVOL2, PCSK9, PPME1, PXN,
RAD51L1, RPL21, RPSA, SMG1, SRRM2, SUV39H2,
TADA3, TEP1, TTF2, TTLL12, USP14, WDR82, ZNF14,
ZNF33A, ZNF417, ZNF430, ZNF454, ZNF542, ZNF549,
ZNF620, ZNF667, ZNF786, ZNF791, ZNF91, ZNF98
33554 Cellular response to
stress
16 7.77 857 ATG10, C9orf80, CDC14B, CREB1, DUSP19, HIPK2, INTS3,
ITCH, MAP3K9, MSH3, PCSK9, PXN, RAD51L1, SMG1,
XIAP, ZMAT3
9059 Macromolecule
biosynthetic process
42 29.01 3200 AHR, AIRE, ATG10, BLZF1, CREB1, DBF4, FOXL2, FUT6,
GABPB2, GNPNAT1, GTF3C6, HIPK2, ID1, ID2, ITCH,
ITGB3, KCNH6, LRRFIP1, MCM8, MITF, MRP63, NAT14,
NFAT5, NFATC3, OVOL2, RPL21, RPSA, TADA3, TTF2,
ZNF14, ZNF33A, ZNF417, ZNF430, ZNF454, ZNF542,
ZNF549, ZNF620, ZNF667, ZNF786, ZNF791, ZNF91,
ZNF98
doi:10.1371/journal.pone.0057751.t006
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cells, 33 were common to the Woroniecka et al. subset, and 25 to
the Schmid et al. subset. For each comparison, only 10.3 genes
were expected by chance. Thus, there are significant excesses in
the overlaps between up-regulated genes in HK-2 cells exposed to
urine from Decliners and subsets of up-regulated genes in the
datasets of Woroniecka et al. and Schmid et al. (p,10
29 and
p,10
24 respectively).
The up-regulated genes in HK-2 cells that overlap with the
biopsy subsets of genes are listed in Table 7. The pattern of
expression of these genes according to the duration of exposure to
urines varied. Over-expression was persistent for 17, temporary for
15 (at 6 hours only), and delayed for 9 (at 24 hours only).
Regardless of these different temporal patterns, all of these genes
were over-expressed in tubular and interstitial compartments of
kidney biopsies obtained from patients with advanced DN, and the
level of their over-expression was strongly but negatively
correlated with eGFR in patients at the time of biopsies (Spearman
correlation coefficients varied between 20.82 and 20.44). These
up-regulated and over-lapping genes were subjected to GO
analysis. The results of the analysis for molecular functions were
similar to the findings reported in Table 3 for all 119 up-regulated
genes (data not shown). The results of the analysis for biological
processes were different and are shown in Table 8. The first two
GO terms defense response and response to other organism are
similar as in Table 4. The other significantly enriched processes
were different and included response to organic substance,
response to drug, cellular response to biologic stimulus, regulation
of cellular processes, innate immune response, and protein
metabolic process.
Discussion
The risk of early GFR decline in T1D patients with MA is
associated with elevated concentrations of several urinary
chemokines, such as IL-6, IL-8, MCP-1(CCL2), IP-10 (CXCL10)
and MIP-1d (CCL15) [5]. Because the concentrations are not
elevated in serum, we postulate that kidney cells, primarily tubular,
are the source of the urinary elevations. The nature of the
stimulus, however, is unknown. We hypothesized that minimal
impairment of the glomerular filtration barrier (evidenced by the
presence of MA) allows certain serum proteins or growth factors to
leak into the urinary space where, in contrast to the vasculature,
they may be toxic to proximal tubular cells and cause damage that
results in synthesis of the elevates chemokines. Furthermore, these
putative toxic urinary proteins (txUPs) should be present
specifically in those patients with MA in whom renal function
decline subsequently develops.
Results of this study in HK-2 cells support our hypothesis.
Following exposure to the urine of Decliners whose renal function
later declined, expression of 314 genes differs from their expression
following exposure to urine from Non-decliners whose function
remained stable. Urine from Decliners led to up-regulation of 119
and down-regulation of 195 genes. In a GO analysis of the up-
regulated genes, two molecular function terms are significantly
enriched. One includes receptor binding terms, and the second
includes peptidase inhibitor activity. With regard to GO terms for
biological processes, up-regulated genes are enriched for the
following processes: defense response, response to other mecha-
nisms, regulation of response to stress, regulation of response to
stimulus and programmed cell death. It is interesting that up-
regulated genes include some that encoded for chemokines,
including those reported by Wolkow et al. [5], CCL2 (MCP-1), IL-
6, and IL-8, and others such as CCL5 (RANTES), CCL20 (MIP-3a),
CSF2 (GMCSF), CXCL2 (MIP-2a), and CXCL3 (MIP-2b) that were
not examined by Wolkow et al. Over-expression of these genes in
HK-2 cells is a coordinated defense response to other organisms or
to stress and is part of programmed cell death. It most likely
accounts for elevated levels of these chemokines in urine.
GO analysis of the down-regulated genes assigns them to
molecular functions such as cation binding, hydrolase activity
acting on ester bonds, and DNA binding. GO terms for biological
processes assigns the down-regulated genes to the regulation of
metabolic processes, nucleic acid metabolic processes, cellular
macromolecule metabolic processes, cellular response to stress and
macromolecule biosynthetic processes. Since all these genes were
under-expressed one can infer that all the above processes are
suppressed in HK-2 cells in response to urines from Decliners.
An important goal of our study was to determine the extent of
overlap between the expression profiles in HK-2 cells exposed to
urine from Decliners and expression profiles in kidney tissue
(tubules and interstitium) of patients with advanced DN and
Figure 2. Overlap of the set of differentially regulated genes in
HK-2 cells in response to urines from Decliners and Non-
decliners and the corresponding sets of genes in tubular and
interstitial compartments of kidney biopsies obtained from
patients with advanced DN. Panel A: Down-regulated genes in HK-
2 cells and in tubular and interstitial compartments of kidney biopsies
(P-value =0.34 for overlap with data of Woroniecka et al. [12] and 0.43
for overlap with data of Schmid et al. [11]). Panel B: Up-regulated
genes in HK-2 cells and in tubular and interstitial compartments of
kidney biopsies (P-value ,10
29 for overlap with data of Woroniecka et
al. [12] and ,10
24 for overlap with data of Schmid et al. [11]).
doi:10.1371/journal.pone.0057751.g002
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and B) up-regulated genes in tubular and interstitial compartment of kidney biopsies obtained from patients with advanced
diabetic nephropathy (genes strongly negatively correlated with eGFR).
A) Findings in HK-2 cells: B) Findings in tubular/interstitial compartment:
Gene Name Entrez ID Fold change (p) Fold change (p)
Woroniecka’s dataset
Spearman Correlation
Schmid’s dataset
Spearman Correlation
6 hrs expos. 24 hrs expos. (r) (p) (r) (p)
Genes up-regulated during both exposures
ADRB2 154 2.13 0.009 1.36 0.002 20.77 0.00
BIRC3 330 1.40 0.126 1.77 0.019 20.67 0.00 20.68 0.01
CCL2 6347 2.27 0.011 1.98 8xE-04 20.70 0.00
CCL5 6352 2.24 0.001 1.83 4xE-05 20.76 0.00
IL8 3576 7.23 0.006 3.23 0.004 20.59 0.00
JAK1 3716 1.75 0.035 1.73 0.017 20.49 0.01
LOX 4015 1.43 0.050 1.67 0.041 20.60 0.03
LCN2 3934 1.87 0.002 5.20 1xE-04 20.59 0.00
NAMPT 10135 1.51 0.004 1.33 0.085 20.49 0.06
NBN 4683 1.34 0.017 1.39 0.027 20.44 0.02 20.46 0.08
PTX3 5806 1.86 0.009 1.31 0.002 20.51 0.06
SLPI 6590 1.76 0.004 2.76 9xE-04 20.69 0.00 20.46 0.08
SOD2 6648 1.69 0.003 1.84 0.001 20.74 0.00
ST5 6764 1.92 0.022 1.31 0.005 20.75 0.00
TFRC 7037 1.47 0.034 1.73 0.002 20.49 0.06
TNFAIP2 7127 2.51 0.004 1.45 0.005 20.80 0.00
TNFRSF1B 7133 1.84 0.009 1.36 0.013 20.68 0.00
Genes up-regulated during 6 hrs. exposure:
BCL2A1 597 2.59 0.005 1.17 0.024 20.62 0.00
DDR1 780 1.31 0.015 1.13 0.173 20.58 0.00 20.51 0.05
DSE 29940 1.82 0.031 1.25 0.155 20.59 0.00 20.55 0.04
FOSL2 2355 1.50 0.010 1.25 0.004 20.51 0.05
ICAM1 3383 1.51 0.003 1.20 0.103 20.61 0.00 20.47 0.07
KIF2A 3796 1.34 0.026 1.09 0.015 20.53 0.01 20.65 0.01
LAMB3 3914 1.84 0.046 1.28 0.006 20.55 0.00
LYN 4067 1.47 0.031 1.14 0.131 20.80 0.00
MYO1B 4430 1.39 0.042 1.25 0.010 20.50 0.01 20.55 0.04
NAP1L1 4673 1.46 0.030 1.13 0.601 20.69 0.00 20.46 0.07
NFKB1 4790 1.77 0.013 1.17 0.024 20.71 0.01
RAC2 5880 1.34 0.008 1.20 0.017 20.75 0.00
SERPINB8 5271 1.58 0.036 0.99 0.826 20.50 0.06
SLC43A3 29015 1.36 0.007 1.11 0.131 20.56 0.00
TRAM1 23471 1.32 0.017 1.10 0.113 20.50 0.01 20.49 0.06
Genes up-regulated during 24 hrs. exposure.
C3 718 1.27 0.075 1.60 0.011 20.78 0.00 20.60 0.02
DHX15 1665 1.23 0.045 1.34 0.007 20.60 0.03
ELF3 1999 1.07 0.446 1.58 0.006 20.50 0.01 20.53 0.05
LAMC2 3918 1.03 0.835 1.34 0.016 20.75 0.00 20.50 0.06
MMP7 4316 1.27 0.045 1.99 3xE-05 20.82 0.00 20.48 0.07
TMEM132A 54972 1.17 0.012 1.31 0.007 20.62 0.00
TNFSF10 8743 1.10 0.299 1.47 0.007 20.82 0.00 20.75 0.00
STAT1 6772 0.89 0.276 1.43 0.003 20.70 0.00 20.54 0.04
WFDC2 10406 1.12 0.197 1.31 0.019 20.79 0.00 20.65 0.02
doi:10.1371/journal.pone.0057751.t007
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regulated in tubules and interstitium in advanced DN as reported
by Schmid et al. and Woroniecka et al., 42 overlapped with up-
regulated genes in HK-2 cells, well beyond the number expected
by chance. This similarity indicates that certain disease processes
in tubules and interstitium present in advanced DN have already
begun when patients have minimal MA and normal renal
function. Quite plausibly, these processes were induced by the
putative txUPs.
What is the nature of txUPs? Many authors have investigated
whether the putative txUPs might be the high concentration of
albumin present in patients with overt proteinuria. Based on in vitro
studies, two processes are proposed to initiate tubulointerstitial
disease. Enhanced protein intake by proximal tubule cells results in
lysosomal rupture and direct tubule toxicity and stimulates
synthesis of cytokine and chemokines that enhance the inflamma-
tory response and activate fibrotic processes in the interstitial
compartment [16,17]. These studies, however, suffered from many
methodological problems, including use of extremely high
concentrations of albumin. Recently Bains and Brunskill [18,19]
reviewed these studies and deemed them inconclusive.
In a just published review Bonventre proposes the hypothesis
that persistent tubular damage initiates inflammation of tubules
and interstitium, loss of blood vessels and interstitial fibrosis and
results in glomerulosclerosis that may lead to renal function
decline [20]. He suggested several possible mechanisms or
exposures that may be responsible for the injury to proximal
tubules in diabetes. Whereas some of them, for example excess of
reactive oxygen species (ROS), are related to abnormal metabo-
lism of glucose in proximal tubule cells per se, the others might be
considered candidates for txUPs. For example, TGF-B1 that is
produced by mesangial cells in the presence of hyperglycemia may
be excreted into the urine. As a pro-fibrotic factor, it may affect
proximal tubules and interstitium. Also, chronic hyperglycemia
results in nonenzymatic glycation of protein and formation of
advanced glycation end-products (AGEs). These are excreted into
the urine and reabsorbed in proximal tubules where they undergo
catabolism. This may result in production of IL-6, IL-8, MCP-1,
CTGF, TGF-B1 and VEGF. Note that the genes for the first three
of these chemokines were up-regulated in our study, and genes for
the remaining three were not.
Several chemokines/cytokines are excreted in excess in urine in
patients with established DN [5,21]. However, until the study by
Wolkow et al. of patients with MA, the ability of chemokines, such
as IL-6, IL-8, MCP-1, IP-10 and MIP-1d, to predict the future
occurrence of early renal function decline was not recognized. As
noted above, several of these chemokines are up-regulated in the
HK-2 cells by exposure to urine from Decliners. Since the
chemokines in the urine cannot up-regulate expression of their
genes in tubules, these chemokines are not the putative txUPs, and
some other stimulus must be involved. A cytokine that has been
implicated in the development of DN, tumor necrosis factor-alpha
(TNFa), could plausibly be that stimulus [22]. Interestingly, many
of the up-regulated genes in our HK-2 cells are up-regulated by in
vitro exposure of renal epithelial cells to TNFa [23,24].
TNFa is a pleiotropic cytokine that plays an essential role in
mediating inflammatory processes [25]. TNF is recognized by two
receptors, TNFR1 and TNFR2. In plasma, TNFa appears as free
or bound to its receptors. Hasegawa et al. were the first to
implicate TNFa in the pathogenesis of DN [22]. Recently we
demonstrated that circulated TNFa and its two receptors were the
strongest predictors of progression to CKD3 in Type 1 diabetes
and ESRD in Type 2 diabetes [4,26]. Although the effects of the
receptors were stronger than TNFa, one cannot exclude the later
as a causal factor due to significant correlation among these three
markers. This difficulty is compounded by measurement problems
of TNFa as free or bound in plasma and serum [26]. Moreover, its
concentration in urine is very low, and we were unable to measure
it reliably (data not shown).
Finally, we ought to acknowledge the strengths and possible
shortcomings of our study. First, application of global transcrip-
tome analysis, rather than an analysis of selected pathways (biased
approach), is a strength. This strength, however, was somewhat
compromised in the search for overlap of our set of up- or down-
regulated pathways in HK-2 cells with the corresponding sets of
genes in tubular/interstitial compartments of kidney biopsies
previously reported [11,12]. The Affymetrix platform used in
those studies included only 61% of the genes represented on our
Illumina platform (12,000 out of 19,600). How much overlap was
Table 8. Overlapping gene: Enriched GO Biological process terms for up-regulated genes in HK2 cells (top 20 enriched BP terms
(P,0.01) were retrieved upstream towards its ancestors to level 4).
GO Term-ID GO Term # Genes observed # Genes expected# Genes total List of observed genes
6952 defense response 15 2.54 910 ADRB2, C3, CCL2, CCL5, ELF3, ICAM1, IL8, JAK1, LCN2, LYN,
NFKB1, PTX3, STAT1, TFRC, TNFRSF1B
51707 response to other
organism
6 1.22 437 CCL2, CCL5, ICAM1, IL8, LCN2, STAT1
10033 response to organic
substance
12 3.37 1209 CCL2, CCL5, DDR1, ICAM1, IL8, JAK1, LCN2, LOX, LYN, STAT1,
TFRC, TNFRSF1B
42493 response to drug 8 0.80 288 CCL2, CCL5, ICAM1, LCN2, LOX, LYN, NBN, STAT1
71216 cellular response to
biotic stimulus
5 0.21 77 CCL2, ICAM1, IL8, LCN2, STAT1
50794* regulation of cellular
process
12 NA 6593 ADRB2, CCL2, CCL5, DDR1, FOSL2, IL8, LYN, MMP7, NAP1L1,
NBN, SOD2, STAT1
45087 innate immune
response
8 1.17 418 C3, CCL2, CCL5, ICAM1, JAK1, LCN2, NFKB1, STAT1
19538 protein metabolic
process
5 0.33 119 CCL5, DDR1, JAK1, LYN, STAT1
*denotes GO term by itself is not significantly enriched, but some of its downstream terms is significantly enriched.
doi:10.1371/journal.pone.0057751.t008
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shortcoming, the significant overlap of the set of up-regulated
genes in our HK-2 cells and the sets in two independent biopsy
studies of diabetic kidneys is a strong validation/replication of our
findings. Second, we used pooled urines from Decliners and Non-
decliners to reduce cost and minimize the difficulty of maintaining
standardized conditions across all experiments, which would be
large number if we examined each patient individually. This
element of the study design is a strength for it most likely increased
the study’s sensitivity. Third, our use of a two-fold concentration of
urine may be seen as a shortcoming. Possibly the concentrations of
the putative txUPs were too low for all relevant genes to be
differentially expressed in our experiments. Our choice was
arbitrary and, to offset this possibility, we performed parallel
studies with exposures of 6 and 24 hours. Fourth, a strength that
distinguishes our study from all other in vitro studies was that the
cultured cells were exposed to serum-free medium. This reduces
exposure of cells to serum growth factors and high concentration
of albumin present in serum. Note: the media contained high
levels of glucose. Fifth, we used immortalized tubular epithelial cell
line HK-2 in our experiments. It is unknown whether the findings
would be the same if primary cultures of tubular epithelial cells
had been used.
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